Table 2 Physical activity outcomes (total weekly minutes) at baseline and 12 months for accelerometry and IPAQ
Group summary data | Treatment effects | |||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Control group (n = 231) | Postal group (n = 207) | Nurse group (n = 217) | Postal vs Control | Nurse vs Control | ||||||||||||
Baseline | 12 months | Baseline | 12 months | Baseline | 12 months | Effect | p-value | Effect | p-value | |||||||
Mean | (sd) | Mean | (sd) | Mean | (sd) | Mean | (sd) | Mean | (sd) | Mean | (sd) | (95% CI) | (95% CI) | |||
Accelerometry outcomes | ||||||||||||||||
Daily step count | 7572 | (2738) | 7402 | (2724) | 7691 | (2560) | 8233 | (3076) | 7487 | (2738) | 8146 | (3224) | 804 (426, 1181) | < 0.001 | 837 (463, 1211) | < 0.001 |
MVPA in ≥10 min bouts (weekly minutes) | 95 | (103) | 97 | (101) | 107 | (95) | 144 | (128) | 107 | (114) | 146 | (149) | 42 (22, 61) | < 0.001 | 43 (24, 63) | < 0.001 |
Total MVPA (weekly minutes) | 319 | (155) | 330 | (160) | 329 | (143) | 377 | (173) | 317 | (157) | 367 | (189) | 43 (20, 65) | < 0.001 | 41 (18, 63) | < 0.001 |
IPAQ outcomes | ||||||||||||||||
IPAQ-MVPA (weekly minutes) | 188 | (300) | 222 | (343) | 171 | (285) | 200 | (288) | 165 | (249) | 180 | (300) | -11 (−65, 42) | 0.68 | −34 (−87, 19) | 0.21 |
IPAQ-Walk (weekly minutes) | 336 | (332) | 356 | (335) | 331 | (336) | 398 | (332) | 286 | (262) | 365 | (309) | 57 (2, 112) | 0.04 | 43 (−11, 97) | 0.12 |
IPAQ-Total (weekly minutes) | 525 | (494) | 578 | (520) | 502 | (481) | 598 | (479) | 450 | (365) | 545 | (456) | 46 (−34, 126) | 0.26 | 14 (−66, 93) | 0.74 |